|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Increased volume of gastric contents in diabetic patients undergoing renal transplantation: lack of effect with cisapride显示文摘 | Taskinen MR Orko R | 1992 | Acta Anaesthesiol Scand1992，36，7： | 1 |
| 2 | Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM 显示文摘 | Malmstrom R Taskinen MR Karonen SL | 1996 | Diabetologia1996，39，8： | 1 |
| 3 | Overproduc-tion of large VLDL particles is driven by increased liver fat content in man显示文摘 | Adiels M Taskinen MR Packard C | 2006 | Diabetologia2006，49，4： | 1 |
| 4 | Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized,double-blind,placebo-controlled study显示文摘 | Taskinen MR Rosenstock J Tamminen I | 2011 | Diabetes Obes Metab2011，13，1： | 1 |
| 5 | Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM显示文摘 | Taskinen MR Karonen SL | 1996 | Diabetologia1996，39，5： | 1 |
| 6 | Cardiovascular morbidity and mortality associated with the metabolic syndrome显示文摘 | Isomaa B Almgren P Tuomi T Forsen B Lahti K Nissen M Taskinen MR Groop L | 2001 | Diabetes Care2001，24，： | 1 |
| 7 | Fatty liver, insulin resistance, and dyslipidemia显示文摘 | Adiels M Taskinen MR BorOn J | 2008 | Curt Diab Rep2008，8，1： | 1 |
| 8 | Diabetic dyslipidaemia: from basic research to elini- calpractiee显示文摘 | Taskinen MR | 2003 | Diabetologia2003，46，6： | 1 |
| 9 | Dose familial hypertriglyceridemia predispose to NIDDM显示文摘 | Sane T Taskinen MR | 1993 | Diabetes Care1993，16，11： | 1 |
| 10 | Monotherapy with the PCSK9 inhibitor alirocumab versus ezetimibe in patients wilb hypercholesterolemia: results of a 24 week, double-blind, randomized Phase 3 trial显示文摘 | Roth EM Taskinen MR Ginsberg HN | 2014 | Int J Cardiol2014，176，1： | 1 |
| 11 | Safety and efficacy of linagliptin as add-an therapy to mefformin in patients with type 2 dia- betes: a randomized double-blind, placebo-controlled study 显示文摘 | Taskinen MR Rosenstock J Tamminen I | 2011 | Diabe- tes Obes Metab2011，13，1： | 1 |
| 12 | Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM显示文摘 | Malmstrom R Taskinen MR Karonen SL et a1 | 1996 | Diabetologia1996，39，8： | 1 |
| 13 | Quantitative comparison of angiographic characteristics of coronary artery disease in patients with noninsulin-dependent diabetes mellitus compared with matched nondiabetic control subjects显示文摘 | Pajunen P Nieminen MS Taskinen MR | 1997 | Am J Cardiol1997，80，5： | 1 |
| 14 | Insulin resistance and lipoprptein metabolism显示文摘 | | 1995 | Curr Opin Lipidology1995，6，： | 1 |
| 15 | Safety and efficacy of linagliptin as add- on therapy to metformin in patients with type 2 diabetes: a randomized, double- blind, placebo-controlled study显示文摘 | TASKINEN MR ROSENSTOCK J TAMMINEN I | 2010 | Diabetes Obes Metab2010，13，1： | 1 |
| 16 | ApoA5 gene variants,lipoprotein particle distribution and progression of coronary heart disease : Results from the LOCAT study显示文摘 | Talmud PJ Martin S Taskinen MR | 2004 | J Lipid Res2004，45，： | 1 |
| 17 | Dual metabolic defects are required to produce hypertriglyceridemia in obese subjects 显示文摘 | Taskinen MR Adiels M Westerbacka J | 2011 | Arterioscler Thromb Vase Biol2011，31，9： | 1 |
| 18 | 'Strategies for the management of diabetic dyslipidcmia显示文摘 | Taskinen MR | 1999 | Drug1999，58，1： | 1 |
| 19 | Testosterone substitution increases the activity of lipoprotein, lipase and hepatic lipase in hypogonadal males显示文摘 | Sorva R Kuusi T Taskinen MR | 1988 | Atherosclerosis1988，69，： | 1 |
| 20 | Type 2 diabetes as a lipid disorder显示文摘 | Taskinen MR | 2005 | Curr Mol Med2005，5，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员